MITA names Dennis Durmis chair of its Board of Directors

Matt O'Connor | | Health Imaging | Policy & Regulations

The Medical Imaging & Technology Alliance (MITA) announced today that Dennis Durmis, senior vice president of Bayer Radiology, Americas region, will be the next chair of its Board of Directors.

Dennis Durmis, MITA
Dennis Durmis. Photo courtesy of MITA.

“It is an honor to serve as the next chair of MITA Board of Directors,” said Durmis, in a prepared statement. “The medical imaging landscape is rapidly changing, and MITA and its Members are at the forefront of advancing the latest innovations and technological developments. I look forward to leading MITA during this exciting time.”

Durmis has been with Bayer for the past 19 years. Prior to assuming his current position, he led Bayer’s global MEDRAD Service business and led all aspects of MEDRAD Emerging Markets growth initiative.

“Denny has been an important leader and an invaluable member of the MITA board,” said Patrick Hope, executive director of MITA, in the same statement. “We look forward to his leadership as chair to guide MITA during this very important time in the medical imaging industry.”

""
Matt O'Connor

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Related Content

University of Missouri Health Care's 7T scanner joins exclusive ACR accreditation club
Radiologist arrested for secretly recording female patient's breasts during imaging
Why cardiac CT adoption remains low among primary care providers
Injuries trigger recall related to tables used during image-guided procedures
New FDA-cleared algorithm could improve fetal anomaly detection on ultrasound
Center for Devices and Radiological Health hit with federal job cuts

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.